Array Biopharma Inc (NASDAQ:ARRY) attains midstage triumph for asthma … – FinancialsTrend


REM

Array Biopharma Inc (NASDAQ:ARRY) attains midstage triumph for asthma
FinancialsTrend
Dallas, Texas 07/24/2013 (Financialstrend) – Array Biopharma Inc (NASDAQ:ARRY) has an additional benefit on deck for a prospective affiliation. The Boulder, CO-based medicine creator has touted upbeat Stage II facts for an experimental medicine in 
Biotech News Bundle: BioCryst, NeoStem, Array Biopharma , Lexicon, GTx REM
Biotech Top Gainers,BioCryst Pharmaceuticals,Array Biopharma,NeoStem PR Carbon (press release)
Biotech Stocks Amid Structural And Capital Change: BioCryst Pharmaceuticals Property Mentor
Galaxy Stocks –Equity Observer
all 10 news articles »

View full post on asthma – Google News